As mentioned above, given VTC is very selective for BCL-2, one of the most important factors that may contribute to a tumor’s susceptibility to BCL-2 inhibition is the level of BCL2 expression that is inherent to the tissue and its survival. The gene discussed is BCL2; the disease is neoplasm.